Literature DB >> 14966287

Id2 is dispensable for Myc-induced epidermal neoplasia.

Daniel J Murphy1, Lamorna Brown Swigart, Mark A Israel, Gerard I Evan.   

Abstract

We have previously described a transgenic mouse model of epidermal neoplasia wherein expression of a switchable form of c-Myc, MycER(TAM), is targeted to the postmitotic suprabasal keratinocytes of murine epidermis via the involucrin promoter. Sustained activation of c-MycER(TAM) results in a progressive neoplastic phenotype characterized by aberrant ectopic proliferation and delayed differentiation of suprabasal keratinocytes, culminating in papillomatosis. Transcription of the Id2 gene is regulated by Myc family proteins. Moreover, Id2 is implicated as a pivotal determinant of cell fate in multiple lineages and has a demonstrated role in mediating Myc-dependent cell proliferation in vitro through its interaction with retinoblastoma protein. Using Id2 nullizygous mice, we assessed in vivo the requirement for Id2 in mediating Myc-induced papilloma formation in skin. We show that absence of Id2 has no discernible impact on any measurable attribute of Myc function or on the timing or extent of eventual tumor formation. Thus, our data argue against any essential role for Id2 in mediating Myc action in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14966287      PMCID: PMC350569          DOI: 10.1128/MCB.24.5.2083-2090.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

1.  Mad upregulation and Id2 repression accompany transforming growth factor (TGF)-beta-mediated epithelial cell growth suppression.

Authors:  Peter M Siegel; Weiping Shu; Joan Massagué
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

Review 2.  Id proteins in cell growth and tumorigenesis.

Authors:  Hashmat A Sikder; Meghann K Devlin; Shariff Dunlap; Byungwoo Ryu; Rhoda M Alani
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

3.  The protein Id: a negative regulator of helix-loop-helix DNA binding proteins.

Authors:  R Benezra; R L Davis; D Lockshon; D L Turner; H Weintraub
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

4.  Gene expression of markers associated with proliferation and differentiation in human keratinocytes cultured from epidermis and from buccal mucosa.

Authors:  M M Brysk; I Arany; H Brysk; S H Chen; K H Calhoun; S K Tyring
Journal:  Arch Oral Biol       Date:  1995-09       Impact factor: 2.633

5.  Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts.

Authors:  D Lyden; A Z Young; D Zagzag; W Yan; W Gerald; R O'Reilly; B L Bader; R O Hynes; Y Zhuang; K Manova; R Benezra
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

6.  Consequences of heteromeric interactions among helix-loop-helix proteins.

Authors:  T Kadesch
Journal:  Cell Growth Differ       Date:  1993-01

7.  Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts.

Authors:  E Hara; T Yamaguchi; H Nojima; T Ide; J Campisi; H Okayama; K Oda
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

Review 8.  Id proteins in development, cell cycle and cancer.

Authors:  Marianna B Ruzinova; Robert Benezra
Journal:  Trends Cell Biol       Date:  2003-08       Impact factor: 20.808

9.  Doxorubicin represses the function of the myogenic helix-loop-helix transcription factor MyoD. Involvement of Id gene induction.

Authors:  M Kurabayashi; R Jeyaseelan; L Kedes
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

10.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

Authors:  T D Littlewood; D C Hancock; P S Danielian; M G Parker; G I Evan
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

View more
  10 in total

1.  Loss of Id2 potentiates the tumorigenic effect of Rb inactivation in a mouse model of retinoblastoma.

Authors:  Solange Landreville; Duanduan Ma; Jun Wu; J William Harbour
Journal:  Curr Eye Res       Date:  2010-05       Impact factor: 2.424

2.  Genetic analysis of myc and telomerase interactions in vivo.

Authors:  Ignacio Flores; Gerard Evan; María A Blasco
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

3.  The Smad7-Skp2 complex orchestrates Myc stability, impacting on the cytostatic effect of TGF-β.

Authors:  Tae-Aug Kim; Jin Muk Kang; Ja-Shil Hyun; Bona Lee; Staci Jakyong Kim; Eun-Sung Yang; Suntaek Hong; Ho-Jae Lee; Makiko Fujii; John E Niederhuber; Seong-Jin Kim
Journal:  J Cell Sci       Date:  2013-11-20       Impact factor: 5.285

4.  Sequestration of E12/E47 and suppression of p27KIP1 play a role in Id2-induced proliferation and tumorigenesis.

Authors:  Valerie A Trabosh; Kyle A Divito; Baltazar D Aguda; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Carcinogenesis       Date:  2009-05-18       Impact factor: 4.944

Review 5.  Paradoxical role of Id proteins in regulating tumorigenic potential of lymphoid cells.

Authors:  Sumedha Roy; Yuan Zhuang
Journal:  Front Med       Date:  2018-07-24       Impact factor: 4.592

6.  The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas.

Authors:  Linus Plym Forshell; Yongmei Li; Tacha Zi Plym Forshell; Martina Rudelius; Lisa Nilsson; Ulrich Keller; Jonas Nilsson
Journal:  Oncotarget       Date:  2011-06

7.  Ovol1 regulates the growth arrest of embryonic epidermal progenitor cells and represses c-myc transcription.

Authors:  Mahalakshmi Nair; Andy Teng; Virginia Bilanchone; Anshu Agrawal; Baoan Li; Xing Dai
Journal:  J Cell Biol       Date:  2006-04-24       Impact factor: 10.539

Review 8.  The Id-protein family in developmental and cancer-associated pathways.

Authors:  Cornelia Roschger; Chiara Cabrele
Journal:  Cell Commun Signal       Date:  2017-01-25       Impact factor: 5.712

Review 9.  Cardiovascular development and the colonizing cardiac neural crest lineage.

Authors:  Paige Snider; Michael Olaopa; Anthony B Firulli; Simon J Conway
Journal:  ScientificWorldJournal       Date:  2007-07-03

10.  siRNA directed against c-Myc inhibits proliferation and downregulates human telomerase reverse transcriptase in human colon cancer Colo 320 cells.

Authors:  Huang Hao; Yu Nancai; Fu Lei; Wei Xiong; Su Wen; Huang Guofu; Wu Yanxia; Huang Hanju; Liu Qian; Xiao Hong
Journal:  J Exp Clin Cancer Res       Date:  2008-08-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.